Benzinga | Aug 5, 2021 04:30PM EDT

Coherus BioSciences Q2 EPS $(0.36) Misses $(0.17) Estimate, Sales $87.64M Miss $89.81M Estimate

Coherus BioSciences (NASDAQ:CHRS) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.17) by 111.76 percent. This is a 144.44 percent decrease over earnings of $0.81 per share from the same period last year. The company reported quarterly sales of $87.64 million which missed the analyst consensus estimate of $89.81 million by 2.41 percent. This is a 35.40 percent decrease over sales of $135.67 million the same period last year.